Magdeburg at Gilead Sciences

Leipzig, Saxony, Germany

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Strong project management skills
Proven ability to work across various functions (frequent interactions with the Business Unit Director, CTAM lead, Medical Director, Medical Scientists, CTAM partners (CTRS), National & Regional Account Directors and the Quality team)
Strong commercial and scientific knowledge (inferred from context)

Responsibilities

Responsible for meeting with appropriate leaders across the qualified centers to continue educate and logistically support the use of Kite product(s)
Ability to navigate a complex account environment and understand the needs/issues of various stakeholders at all levels within the account
Coordination of the cell journey to ensure a high level of patient access and cell delivery
Closely works with Market Access colleagues meeting government representatives to enable reimbursement of cell therapy locally or nationally
Collaborates with Head-Office and Medical teams to develop and implement key account plans
Collaborate and regularly communicate with colleagues in commercial, quality and medical affairs
Actively gains customer insights, providing timely follow-up on commitments and requests
Operate in compliance with all laws, regulations and policies
Develop significant relationships with Therapy Area Experts (TAEs), senior account level leadership, as well as other decision makers and influencers
Provide Medical Affairs and Commercial colleagues with appropriate feedback and insights from interactions with healthcare professionals (HCPs)
Provide support at professional meetings, including staffing exhibits, reporting on scientific sessions, and facilitating meetings with TAEs
Facilitate and provide timely feedback to appropriate management regarding account business trends, changes in the therapeutic landscape, industry issues and business opportunities
Collaborate regularly with CTRSs to coordinate HCP interactions and align on consistent and harmonized delivery of key differentiating messages
Assessing, cultivating and managing professional relationships across broad stakeholder groups within targeted Cell Therapy qualified treatment centres
Maintaining world-class, patient centric operations in a defined number of existing qualified treatment centres
Project managing the qualification of new centers to ensure the successful introduction and use of Kite products
Engagement with key stakeholders at all levels to drive differentiation and continue establishing Kite as the leader in cell therapy

Skills

Account Management

Stakeholder Management

Project Management

Cell Therapy

Treatment Center Qualification

Commercial Operations

Patient Centricity

Pharma Sales

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free